Glucokinase maturity-onset diabetes of the young as a mimicker of stress hyperglycemia: a case report

被引:0
作者
Nakasato, Yoshitaka [1 ]
Terashita, Shintaro [2 ,7 ]
Kusabiraki, Shohei [1 ]
Horie, Sadashi [2 ]
Wada, Takuya [3 ]
Nakabayashi, Motokazu [4 ]
Nakamura, Megumi [5 ]
Yorifuji, Tohru [6 ]
机构
[1] Itoigawa Gen Hosp, Dept Pediat, Niigata, Japan
[2] Toyama Univ Hosp, Dept Pediat, Toyama, Japan
[3] Toyama City Hosp, Dept Pediat, Toyama, Japan
[4] Hida Municipal Hosp, Dept Pediat, Gifu, Japan
[5] Nakamura Childrens Clin, Niigata, Japan
[6] Osaka City Gen Hosp, Childrens Med Ctr, Div Pediat Endocrinol & Metab, Osaka, Japan
[7] Univ Toyama, Fac Med, Dept Pediat, 2630 Sugitani, Toyama, Toyama 9300194, Japan
关键词
glucokinase; stress hyperglycemia; maturity-onset diabetes of the young; PREVALENCE; CHILDREN; MODY;
D O I
10.1297/cpe.32.2022-0024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Febrile seizures are frequently accompanied by stress-induced hyperglycemia. Herein, we report the case of a 1.5-yr-old girl with hyperglycemia during febrile seizures who was subsequently diagnosed with glucokinase (GCK) maturity-onset diabetes of the young (MODY), considering its distinction from stress hyperglycemia. Following the development of febrile seizures owing to adenovirus infection, the patient presented a casual blood glucose level was 185 mg/dL. She had a multigenerational family history of diabetes and a hemoglobin A1c (HbA1c) level of 6.4%. Owing to the persistent glucose intolerance until the age of 5 years, genetic testing was performed, which revealed a heterozygous mutation in GCK, and the patient was diagnosed with GCK-MODY. Precise diagnosis of GCK-MODY individuals is important to avoid administering unnecessary antidiabetic medications. Even during hyperglycemia under stress, multigenerational diabetes and mildly elevated HbA1c levels can suggest GCK-MODY.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 15 条
  • [1] Ballerini MG, 2016, ARCH ARGENT PEDIATR, V114, P329, DOI [10.5546/aap.2016.eng.329, 10.5546/aap.2016.329]
  • [2] Approach to the Patient with MODY-Monogenic Diabetes
    Broome, David T.
    Pantalone, Kevin M.
    Kashyap, Sangeeta R.
    Philipson, Louis H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01) : 237 - 250
  • [3] GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated
    Carmody, David
    Naylor, Rochelle N.
    Bell, Charles D.
    Berry, Shivani
    Montgomery, Jazzmyne T.
    Tadie, Elizabeth C.
    Hwang, Jessica L.
    Greeley, Siri Atma W.
    Philipson, Louis H.
    [J]. ACTA DIABETOLOGICA, 2016, 53 (05) : 703 - 708
  • [4] The 0.1% of the Population With Glucokinase Monogenic Diabetes Can Be Recognized by Clinical Characteristics in Pregnancy: The Atlantic Diabetes in Pregnancy Cohort
    Chakera, Ali J.
    Spyer, Gill
    Vincent, Nicola
    Ellard, Sian
    Hattersley, Andrew T.
    Dunne, Fidelma P.
    [J]. DIABETES CARE, 2014, 37 (05) : 1230 - 1236
  • [5] Stress Hyperglycemia as Predictive Factor of Recurrence in Children with Febrile Seizures
    Costea, Raluca Maria
    Maniu, Ionela
    Dobrota, Luminita
    Neamtu, Bogdan
    [J]. BRAIN SCIENCES, 2020, 10 (03)
  • [6] Stress hyperglycaemia
    Dungan, Kathleen M.
    Braithwaite, Susan S.
    Preiser, Jean-Charles
    [J]. LANCET, 2009, 373 (9677) : 1798 - 1807
  • [7] Non-Diabetic Hyperglycemia in the Pediatric Age: Why, How, and When to Treat?
    Fattorusso, Valentina
    Nugnes, Rosa
    Casertano, Alberto
    Valerio, Giuliana
    Mozzillo, Enza
    Franzese, Adriana
    [J]. CURRENT DIABETES REPORTS, 2018, 18 (12)
  • [8] CLOSE LINKAGE OF GLUCOKINASE LOCUS ON CHROMOSOME-7P TO EARLY-ONSET NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    FROGUEL, P
    VAXILLAIRE, M
    SUN, F
    VELHO, G
    ZOUALI, H
    BUTEL, MO
    LESAGE, S
    VIONNET, N
    CLEMENT, K
    FOUGEROUSSE, F
    TANIZAWA, Y
    WEISSENBACH, J
    BECKMANN, JS
    LATHROP, GM
    PASSA, P
    PERMUTT, MA
    COHEN, D
    [J]. NATURE, 1992, 356 (6365) : 162 - 164
  • [9] The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
    GoodSmith, Matthew S.
    Skandari, M. Reza
    Huang, Elbert S.
    Naylor, Rochelle N.
    [J]. DIABETES CARE, 2019, 42 (12) : 2247 - 2255
  • [10] Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
    Naylor, Rochelle N.
    John, Priya M.
    Winn, Aaron N.
    Carmody, David
    Greeley, Siri Atma W.
    Philipson, Louis H.
    Bell, Graeme I.
    Huang, Elbert S.
    [J]. DIABETES CARE, 2014, 37 (01) : 202 - 209